ClinicalTrials.Veeva

Menu

Investigation of Benegut® on Immediate GI Discomfort Relief Caused by Acute Overfeeding in Healthy Subjects

V

Vital Solutions Swiss

Status

Active, not recruiting

Conditions

Healthy Volunteers

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Perilla frutescens extract

Study type

Interventional

Funder types

Industry

Identifiers

NCT05603416
BTS1308/19

Details and patient eligibility

About

To determine the relief of GI discomfort after overfeeding with a high caloric meal.

Enrollment

30 patients

Sex

All

Ages

25 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy volunteers without clinical diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility.
  • Age ≥ 25 and ≤ 70 years
  • BMI: 19-30 kg/m2
  • Overall GI discomfort after high caloric meal of at least 5 on the VAS scale
  • Male or female
  • Written consent to participate in the study
  • Subject is able and willing to follow the study protocol procedures
  • If applicable, stable intake of chronic medication of at least 3 months

Exclusion criteria

Criteria for inclusion:

  • Healthy volunteers without clinical diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility.
  • Age ≥ 25 and ≤ 70 years
  • BMI: 19-30 kg/m2
  • Overall GI discomfort after high caloric meal of at least 5 on the VAS scale
  • Male or female
  • Written consent to participate in the study
  • Subject is able and willing to follow the study protocol procedures
  • If applicable, stable intake of chronic medication of at least 3 months

Criteria for exclusion:

  • Relevant history, presence of any medical disorder (e.g. cancer, severe liver disease, severe renal disease, severe cardiovascular disease)
  • Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs or use of PPI (proton pump inhibitors) or other digestive auxiliaries potentially interfering with this study at screening
  • Intake of antibiotics in the last 4 weeks
  • Women suffering from distinct PMS symptoms
  • Acute gastrointestinal diseases including diarrhea and/or vomiting within the last 2 weeks
  • Change of dietary habits within the 4 weeks prior to screening (for instance start of a diet high in fibers)
  • Vegetarian or vegan nutrition style
  • Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject.
  • Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study.
  • Participation in another clinical intervention study within the last 4 weeks and concurrent participation in another intervention clinical study
  • Subject who according to the study staff's opinion is not suitable for participation in the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

30 participants in 2 patient groups, including a placebo group

Benegut
Active Comparator group
Description:
Dietary Supplement: Perilla frutescens extract
Treatment:
Dietary Supplement: Perilla frutescens extract
Placebo
Placebo Comparator group
Description:
Dietary Supplement: Placebo, no active ingredient
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems